WHO high-level event galvanizes commitment and action to accelerate the global drive to scale up TB prevention

A joint Call to Action 2.0, released by WHO and partners, calls for urgent actions by governments and donors to step up momentum to rapidly enhance coverage of TB preventive treatment for those in need.

Read More →

WHO releases new global lists of high-burden countries

The World Health Organization releases new global lists of high-burden countries for TB, HIV-associated TB and drug-resistant TB.

Read More →

Stop TB Partnership launches 2021 Kochon Prize call for nominations

Celebrating TB heroes during the COVID-19 pandemic.

Read More →

World leaders adopt ambitious Political Declaration in the fight to end HIV/AIDS and TB

The 2021 Political Declaration on HIV and AIDS, adopted by world leaders, commits to end HIV/AIDS and TB by 2030 and reverse the progress lost due to the COVID-19 pandemic.

Read More →

Report on governance of the TB response in 22 countries

The Stop TB Partnership and USAID launch a new report assessing the governance of National TB Programmes in 22 countries which together account for over 70% of the global TB burden.

Read More →

TAG launches new TB training resources

The tools are meant to help build awareness of TB in communities, share information on the latest scientific and policy developments, and inform activism to address barriers to TB diagnosis, treatment, and care.

Read More →

Launched: Global online consultation to develop the Global Plan to End TB 2023-2030

The Stop TB Partnership launches the first of two online consultations to inform the development of the new Global Plan to End TB for the period 2023 to 2030.

Read More →

Time for $5 Coalition statement: Cepheid’s updated GeneXpert pricing does not address country needs

The Time for $5 Coalition calls out Cepheid for not including price reductions of Xpert tests in their updated GeneXpert pricing packages for low- and middle-income countries.

Read More →

Landmark TB trials results published in New England Journal of Medicine

A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.

Read More →

Call for applications! Malaria, hepatitis C, and latent TB infection long-acting technologies community advisory board

TAG and AfroCAB are inviting applications from treatment activists and community leaders for a new cross-disease long-acting technologies community advisory board. The deadline to apply is 21 May 2021.

Read More →

Page 1 of 110 · Total posts: 10

1 2 Last→

To subscribe to the Weekly Newsletter of new posts, enter your email here:

Learn About TB